Optometrists in San Sebastian, PR Accepting Medicare

11 Optometrists found. Showing 1 - 11

Centro Optica Vision, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: Avenida Emerito Estrada Rivera, Numero 544, San Sebastian, PR 00685 Phone: 787-316-6112

Dr. Jose Antonio Santisteban, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1003 Ave Emerito Estrada, Suite # 7, San Sebastian, PR 00685 Phone: 787-896-1868

Dr. Zaira Teresa Olivencia Henriquez, OD Optometrist Medicare: Medicare Enrolled Practice Location: 281 Calle Ruiz Belvis, San Sebastian, PR 00685 Phone: 787-896-7040

Mrs. Karla Janixa Velez Quintana, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4100 Ave Arcadio Estrada, Ste 283, San Sebastian, PR 00685 Phone: 787-896-7021

Magaly Gonzalez Mestre, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 Ruiz Belvis, San Sebastian, PR 00685 Phone: 787-280-6986    Fax: 787-280-6988

Dr. Jose Santisteban Optometra Del Desarrollo Psc Optometrist Medicare: Medicare Enrolled Practice Location: # 1003 Ave. Emerito Estrada Rivera, Suite 7, San Sebastian, PR 00685 Phone: 787-896-1868

Janisse N Santiago-gonzalez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 27 Calle Betances, San Sebastian, PR 00685 Phone: 787-280-4681    Fax: 787-280-4532

Ojos Centro Optico Llc Optometrist Medicare: Medicare Enrolled Practice Location: 281 Calle Ruiz Belvis, San Sebastian, PR 00685 Phone: 787-896-7040    Fax: 787-896-7050

Dr. Joannie Irizarry Cortes, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Calle Ruiz Belvis, San Sebastian, PR 00685 Phone: 787-280-6986

Dr. Jose Ricardo Lopez, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 281 Calle Ruiz Belvis, San Sebastian, PR 00685 Phone: 787-896-7040    Fax: 787-896-7050

Dr. Elga Enid Chaves, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4100 Ave Arcadio Estrada, San Sebastian Shopping Center, San Sebastian, PR 00685 Phone: 787-896-7021    Fax: 787-896-7041

News Archive

Cancer patients report less fatigue while taking narcolepsy drug

A large, phase III clinical study showed the drug modafinil (Provigil) alleviated severe cancer-related fatigue for many patients, paving the way for the first reliable treatment for this debilitating and common side effect.

Cancer drug capecitabine causes patient to lose fingerprints and be detained by U.S. immigration

Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.

Continued investment needed to maintain gains against malaria

In this post in Management Sciences for Health's (MSH) "Global Health Impact" blog, Frederick Hartman, the global technical lead for communicable diseases and epidemic preparedness, and regional portfolio director, East Africa at the Center for Health Services at MSH, examines advances made in malaria control over the past decade, writing, "Malaria is still one of the five leading causes of child under-five mortality worldwide, and deserves continuing attention."

Research shows specific damage to nervous system in veterans with Gulf War syndrome

UT Southwestern researchers report that damage to the parasympathetic nervous system may account for nearly half of the typical symptoms - including gallbladder disease, unrefreshing sleep, depression, joint pain, chronic diarrhea and sexual dysfunction - that afflict those with Gulf War syndrome. Their findings will be published in the October issue of the American Journal of Medicine and are currently available online.

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.

Read more Medical News

› Verified 5 days ago